The burgeoning landscape of emerging treatments for metabolic management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a https://dawudbzcv510955.fliplife-wiki.com/4447799/retatrutide_vs_tirzepatide_a_comparative_analysis